CoChat

Chemerin regulates β-cell function in mice

Open access

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Although various function of chemerin have been suggested, its physiological role remains to be elucidated. Here we show that chemerin-deficient mice are glucose intolerant irrespective of exhibiting reduced macrophage accumulation in adipose tissue. The glucose intolerance was mainly due to increased hepatic glucose production and impaired insulin secretion. Chemerin and its receptor ChemR23 were expressed in β-cell. Studies using isolated islets and perfused pancreas revealed impaired glucose-dependent insulin secretion (GSIS) in chemerin-deficient mice. Conversely, chemerin transgenic mice revealed enhanced GSIS and improved glucose tolerance. Expression of MafA, a pivotal transcriptional factor for β-cell function, was downregulated in chemerin-deficient islets and a chemerin-ablated β-cell line and rescue of MafA expression restored GSIS, indicating that chemerin regulates β-cell function via maintaining MafA expression. These results indicate that chemerin regulates β-cell function and plays an important role in glucose homeostasis in a tissue-dependent manner.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep00123

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Chemerin-deficient mice exhibit impaired glucose tolerance and enhanced glucose production in the liver. (a) Intraperitoneal glucose tolerance test in 12-week-old chemerin (+/+) and (−/−) mice. (n = 5–6/genotype). (b) Glucose infusion rate (GIR) at steady-state blood glucose, a measure of general insulin sensitivity, was determined by euglycemic clamp studies. Ten to 14 week-old mice were used for these studies. (n = 6/genotype). (c) Steady-state glucose disposable rate (Rd), a measure of insulin-dependent glucose uptake in the muscle, was calculated as described in Supplementary Methods. (d) Basal hepatic glucose production. (e) Clamp hepatic glucose production at the steady-state were calculated. (f) Liver weights of 10 week-old chemerin (+/+) and (−/−) mice. (g) H&E sections of liver in chemerin (+/+) and (−/−) mice. (400×) (h) Relative expression of genes related to glucose production in mice liver during steady-state conditions in clamp studies using quantitative real-time PCR. (n = 6/genotype). (i, j) Activation of insulin signaling in gastrocnemius muscle (i) and epididymal fat (j) of 12-week-old chemerin (+/+) and (−/−) mice. Insulin at a dose of 10 U/kg was intraperitoneally administered, and the mice were sacrificed 15 min later. Lysates of indicated tissues were subjected to immunoblotting analysis for Ser473-phosphorylated forms of Akt. (n = 3/genotype).
Figure 1 Chemerin-deficient mice exhibit impaired glucose tolerance and enhanced glucose production in the liver. (a) Intraperitoneal glucose tolerance test in 12-week-old chemerin (+/+) and (−/−) mice. (n = 5–6/genotype). (b) Glucose infusion rate (GIR) at steady-state blood glucose, a measure of general insulin sensitivity, was determined by euglycemic clamp studies. Ten to 14 week-old mice were used for these studies. (n = 6/genotype). (c) Steady-state glucose disposable rate (Rd), a measure of insulin-dependent glucose uptake in the muscle, was calculated as described in Supplementary Methods. (d) Basal hepatic glucose production. (e) Clamp hepatic glucose production at the steady-state were calculated. (f) Liver weights of 10 week-old chemerin (+/+) and (−/−) mice. (g) H&E sections of liver in chemerin (+/+) and (−/−) mice. (400×) (h) Relative expression of genes related to glucose production in mice liver during steady-state conditions in clamp studies using quantitative real-time PCR. (n = 6/genotype). (i, j) Activation of insulin signaling in gastrocnemius muscle (i) and epididymal fat (j) of 12-week-old chemerin (+/+) and (−/−) mice. Insulin at a dose of 10 U/kg was intraperitoneally administered, and the mice were sacrificed 15 min later. Lysates of indicated tissues were subjected to immunoblotting analysis for Ser473-phosphorylated forms of Akt. (n = 3/genotype).CC BY-NC-SA · PubMed Central
Figure 2 Phenotypic analysis of adipose tissue in chemerin-deficient mice. (a) Weights of epididymal fat in 10-week-old chemerin (+/+) and (−/−) mice. (b) H&E sections of epididymal fat tissue from chemerin (+/+) and (−/−) mice. (100×) (c) Expression of adipocyte markers in epididymal adipose tissue. (n = 4–5/genotype). (d) Immunohistochemical detection of Mac3 in epididymal adipose tissue of 10-week-old (+/+) and (−/−) mice. Macrophages are stained brown. (400×) (e) Macrophage infiltration into epididymal fat tissue was quantified as the ratio of Mac3-positive cells to total cells. Data are mean ± SEM. (n = 3/genotype). (f) Serum leptin and adiponectin concentrations in chemerin (+/+) and (−/−) mice. (n = 6/genotype).
Figure 2 Phenotypic analysis of adipose tissue in chemerin-deficient mice. (a) Weights of epididymal fat in 10-week-old chemerin (+/+) and (−/−) mice. (b) H&E sections of epididymal fat tissue from chemerin (+/+) and (−/−) mice. (100×) (c) Expression of adipocyte markers in epididymal adipose tissue. (n = 4–5/genotype). (d) Immunohistochemical detection of Mac3 in epididymal adipose tissue of 10-week-old (+/+) and (−/−) mice. Macrophages are stained brown. (400×) (e) Macrophage infiltration into epididymal fat tissue was quantified as the ratio of Mac3-positive cells to total cells. Data are mean ± SEM. (n = 3/genotype). (f) Serum leptin and adiponectin concentrations in chemerin (+/+) and (−/−) mice. (n = 6/genotype).CC BY-NC-SA · PubMed Central
Figure 3 Chemerin and its receptor expression in β- cells. (a) Northern blotting analysis of chemerin in human tissues. Relative mRNA expression of (b) ChemR23, (c) GPR1, and (d) CCRL2 in mouse tissues evaluated by quantitative real time PCR analysis (QRPCR). (e) Immunofluorescence analysis of the chemerin receptor, ChemR23, chemerin and insulin in the mouse islets. (f) QRPCR analysis of ChemR23 and chemerin expressions in pancreas from HFD-fed mice, db/db mice, and streptozotocin (STZ)-induced diabetic mice. (n = 4/group). (h) Immunofluorescence analysis of ChemR23 and insulin in chemerin (+/+) and (−/−) islets.
Figure 3 Chemerin and its receptor expression in β- cells. (a) Northern blotting analysis of chemerin in human tissues. Relative mRNA expression of (b) ChemR23, (c) GPR1, and (d) CCRL2 in mouse tissues evaluated by quantitative real time PCR analysis (QRPCR). (e) Immunofluorescence analysis of the chemerin receptor, ChemR23, chemerin and insulin in the mouse islets. (f) QRPCR analysis of ChemR23 and chemerin expressions in pancreas from HFD-fed mice, db/db mice, and streptozotocin (STZ)-induced diabetic mice. (n = 4/group). (h) Immunofluorescence analysis of ChemR23 and insulin in chemerin (+/+) and (−/−) islets.CC BY-NC-SA · PubMed Central
Figure 4 Impaired glucose-stimulated insulin secretion (GSIS) in chemerin-deficient pancreas, islets and MIN6 cells. (a) Histological analysis of pancreas by H&E staining in chemerin (+/+) and (−/−) mice. Representative images are shown. (b) Percent islet area in 15-week-old (+/+) and (−/−) mice. (n = 4/genotype). (c) Serum insulin levels after glucose administration in 14-week-old mice. (n = 6/genotype). (d) Insulin secretion in islets isolated from at 12-14 week-old (+/+) and (−/−) mice. (n = 6 /genotype). (e) Insulin content in islets isolated from (+/+) and (−/−) mice. (f) In situ pancreatic perfusion in chemerin (−/−) mice. Insulin release was measured from perfused pancreata of (+/+) and (−/−) mice after the indicated stimuli. (n = 5–6/genotype). (g) The amount of insulin released (area under the curve [AUC]) after stimulation with 16.7 mM glucose. The AUC was significantly decreased in chemerin (−/−) pancreas. (h) The AUC was significantly decreased in chemerin (−/−) pancreas after KCl stimulation. (i) Immunohistochemical analysis of ChemR23 in MIN6 cells. (j) Knockdown of chemerin or ChemR23 in MIN6 cells. (k) GSIS was significantly reduced in chemerin- and ChemR23-knockdown MIN6 cells.
Figure 4 Impaired glucose-stimulated insulin secretion (GSIS) in chemerin-deficient pancreas, islets and MIN6 cells. (a) Histological analysis of pancreas by H&E staining in chemerin (+/+) and (−/−) mice. Representative images are shown. (b) Percent islet area in 15-week-old (+/+) and (−/−) mice. (n = 4/genotype). (c) Serum insulin levels after glucose administration in 14-week-old mice. (n = 6/genotype). (d) Insulin secretion in islets isolated from at 12-14 week-old (+/+) and (−/−) mice. (n = 6 /genotype). (e) Insulin content in islets isolated from (+/+) and (−/−) mice. (f) In situ pancreatic perfusion in chemerin (−/−) mice. Insulin release was measured from perfused pancreata of (+/+) and (−/−) mice after the indicated stimuli. (n = 5–6/genotype). (g) The amount of insulin released (area under the curve [AUC]) after stimulation with 16.7 mM glucose. The AUC was significantly decreased in chemerin (−/−) pancreas. (h) The AUC was significantly decreased in chemerin (−/−) pancreas after KCl stimulation. (i) Immunohistochemical analysis of ChemR23 in MIN6 cells. (j) Knockdown of chemerin or ChemR23 in MIN6 cells. (k) GSIS was significantly reduced in chemerin- and ChemR23-knockdown MIN6 cells.CC BY-NC-SA · PubMed Central
Figure 5 Effects of HFD on chemerin-deficient mice and GSIS in chemerin-transgenic mice. (a) Body weights of chemerin (+/+) and (−/−) mice after HFD. Body weights were determined 6 weeks after high-fat diet feeding from 8 weeks of age. (n = 5-8/genotype). (b) Intraperitoneal glucose tolerance test after 8 weeks of HFD in (+/+) and (−/−) mice. (n = 5/genotype). (c) Serum insulin levels after glucose administration following HFD in (+/+) and (−/−) mice. (n = 5/genotype). (d) Characterization of SAP promoter-driven chemerin transgenic mice. Serum (5 μL each) from Tg1, Tg2, wild-type, and chemerin (−/−) mice was subjected to immunoblotting analysis for chemerin. (e) Quantification of serum chemerin concentrations in chemerin transgenic mice. (f) Intraperitoneal glucose tolerance test in 12-week-old chemerin transgenic and wild-type mice. (n = 5/genotype). (g) Serum insulin levels after glucose administration in chemerin transgenic and wild-type mice. (n = 5/genotype).
Figure 5 Effects of HFD on chemerin-deficient mice and GSIS in chemerin-transgenic mice. (a) Body weights of chemerin (+/+) and (−/−) mice after HFD. Body weights were determined 6 weeks after high-fat diet feeding from 8 weeks of age. (n = 5-8/genotype). (b) Intraperitoneal glucose tolerance test after 8 weeks of HFD in (+/+) and (−/−) mice. (n = 5/genotype). (c) Serum insulin levels after glucose administration following HFD in (+/+) and (−/−) mice. (n = 5/genotype). (d) Characterization of SAP promoter-driven chemerin transgenic mice. Serum (5 μL each) from Tg1, Tg2, wild-type, and chemerin (−/−) mice was subjected to immunoblotting analysis for chemerin. (e) Quantification of serum chemerin concentrations in chemerin transgenic mice. (f) Intraperitoneal glucose tolerance test in 12-week-old chemerin transgenic and wild-type mice. (n = 5/genotype). (g) Serum insulin levels after glucose administration in chemerin transgenic and wild-type mice. (n = 5/genotype).CC BY-NC-SA · PubMed Central
Figure 6 MafA is regulated by chemerin and rescue of MafA expression in chemerin-deficient islets or chemerin-knockdown MIN6 cells restores GSIS. (a) MafA and Glut2 mRNA levels were significantly lower in the islets from 12–14-week-old chemerin (−/−) mice than in those of (+/+) mice. (n = 5–6/genotype). (b) MafA protein expression was downregulated in chemerin (−/−) islets. (c) Quantitative analysis of MafA protein expression in islets from 12–14-week-old chemerin (+/+) and (−/−) mice. (n = 3/genotype). (d) Immunohistochemical analysis of MafA expression in chemerin (+/+) and (−/−) islets. Similar results were obtained from three independent experiments. Representative results are shown. (e, f) MafA mRNA (e) and protein (f) expression were downregulated in chemerin- and ChemR23- knockdown MIN6 cells. (g) Rescue of MafA expression in isolated islets using MafA expressing adenovirus. Islets were infected with control (LacZ) or MafA adenovirus at a MOI of 125. (h) The impaired GSIS in chemerin-deficient islets was partially restored by exogenous MafA expression. Similar results were obtained from 3 independent experiments. Representative results are shown (age, 10–15 weeks; n = 3/genotype). (i) Rescue of MafA expression in chemerin-knockdown MIN6 cells infected with control (LacZ) or MafA adenovirus at a MOI of 8. (j) The impaired GSIS in chemerin-knockdown MIN6 cells was restored by exogenous MafA expression (n = 6).
Figure 6 MafA is regulated by chemerin and rescue of MafA expression in chemerin-deficient islets or chemerin-knockdown MIN6 cells restores GSIS. (a) MafA and Glut2 mRNA levels were significantly lower in the islets from 12–14-week-old chemerin (−/−) mice than in those of (+/+) mice. (n = 5–6/genotype). (b) MafA protein expression was downregulated in chemerin (−/−) islets. (c) Quantitative analysis of MafA protein expression in islets from 12–14-week-old chemerin (+/+) and (−/−) mice. (n = 3/genotype). (d) Immunohistochemical analysis of MafA expression in chemerin (+/+) and (−/−) islets. Similar results were obtained from three independent experiments. Representative results are shown. (e, f) MafA mRNA (e) and protein (f) expression were downregulated in chemerin- and ChemR23- knockdown MIN6 cells. (g) Rescue of MafA expression in isolated islets using MafA expressing adenovirus. Islets were infected with control (LacZ) or MafA adenovirus at a MOI of 125. (h) The impaired GSIS in chemerin-deficient islets was partially restored by exogenous MafA expression. Similar results were obtained from 3 independent experiments. Representative results are shown (age, 10–15 weeks; n = 3/genotype). (i) Rescue of MafA expression in chemerin-knockdown MIN6 cells infected with control (LacZ) or MafA adenovirus at a MOI of 8. (j) The impaired GSIS in chemerin-knockdown MIN6 cells was restored by exogenous MafA expression (n = 6).CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Research works printed but not linked: 1

  1. Ernst, M. C. & Sinal, C. J. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 21, 660–667 (2010). · DOI · Paper page

Cited by

Items 101–165 of 165

Metadata

Authors
Takahashi, M., Okimura, Y., Iguchi, G., Nishizawa, H., Yamamoto, M., Suda, K., Kitazawa, R., Fujimoto, W., Takahashi, K., Zolotaryov, F. N., Hong, K. S., Kiyonari, H., Abe, T., Kaji, H., Kitazawa, S., Kasuga, M., Chihara, K., & Takahashi, Y.
Affiliations
  • Kobe University (JP)
  • Kobe Women's University (JP)
  • JCR Pharmaceuticals (Japan) (JP)
  • RIKEN (JP)
  • University of Hyogo (JP)
  • Ehime University (JP)
  • Hyogo Prefectural Kakogawa Medical Center (JP)
Corresponding author
Takahashi, Yutaka
Venue
Scientific Reports
Published
2011-10-19
Volume
1
Issue
1
Pages
123-123
ISSN
2045-2322 (ISSN-L)
OpenAlex
W1977282990
Cited by
149
References
37
Citations by year
2026: 1 · 2025: 8 · 2024: 8 · 2023: 9 · 2022: 12 · 2021: 16 · 2020: 12 · 2019: 13 · 2018: 18 · 2017: 7 · 2016: 7 · 2015: 11 · 2014: 7 · 2013: 12 · 2012: 8
FWCI
8.83
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology (23659477, 22591012)
  • Japan Society for the Promotion of Science (22591012, 23659186, 21590419, 23659477)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
chemerin, ChemR23, beta-cell function, glucose-dependent insulin secretion, impaired glucose tolerance, hepatic glucose production, MafA, glucose homeostasis, adipose tissue macrophages
MeSH terms
Insulin Secretion, Adipose Tissue, Animals, Cell Line, Chemotactic Factors, Glucose Tolerance Test, Insulin, Macrophages, Male, Mice, Inbred C57BL, Mice, Transgenic, Mice, Knockout, Chemokines, Receptors, Chemokine, Intercellular Signaling Peptides and Proteins, Receptors, G-Protein-Coupled, Insulin-Secreting Cells, Mice, Maf Transcription Factors, Large, Gene Knockdown Techniques, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.